{"id":46809,"date":"2022-08-02T02:01:54","date_gmt":"2022-08-02T00:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/"},"modified":"2022-08-02T02:01:54","modified_gmt":"2022-08-02T00:01:54","slug":"correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/","title":{"rendered":"CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae"},"content":{"rendered":"
\n

\nCompany to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol<\/i>\n<\/p>\n

FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare<\/a>–Headline of release dated July 26, 2022, should read: Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae\n<\/p>\n

<\/a><\/p>\n

\nThe updated release reads:\n<\/p>\n

\nSOLEO HEALTH SELECTED AS LIMITED DRUG DISTRIBUTION PARTNER FOR ADMINISTRATION OF LEQVIO\u00ae<\/span><\/b>\n<\/p>\n

\nCompany to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol<\/i>\n<\/p>\n

\nSoleo Health<\/a>, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been selected as a limited distribution partner for cardiovascular drug LEQVIO\u00ae<\/a>, manufactured by Novartis<\/a>, a leading global medicines company.\n<\/p>\n

\nLEQVIO (inclisiran) injection is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) who require additional lowering of low-density lipoprotein cholesterol (LDL-C).\n<\/p>\n

\nLEQVIO is a subcutaneous injection that Soleo Health will administer to patients in their homes or at one of the Company\u2019s Ambulatory Infusion Centers (AICs) nationwide.\n<\/p>\n

\nConcurrent with the administration of LEQVIO, Soleo Health will leverage its proprietary clinical outcomes program, SoleMetrics\u00ae<\/a>, to collect and produce valuable real-world data over time for those patients prescribed LEQVIO. SoleMetrics will gather intelligent outcomes from patients throughout their journeys while on LEQVIO to deliver clinical and economic value to key stakeholders.\n<\/p>\n

\n\u201cSoleo Health\u2019s expertise in caring for patients with complex conditions and our ability to offer services in the home or alternate sites of care creates additional value for pharmaceutical manufacturers. We continue to expand our limited distribution partnerships with numerous drug manufacturers as they appreciate our dedication to clinical excellence and high-quality care,\u201d stated Drew Walk, Soleo Health chief executive officer.\n<\/p>\n

\nAbout Soleo Health<\/b>\n<\/p>\n

\nSoleo Health<\/a> is an innovative national provider of complex specialty pharmacy services administered in the home or at alternate sites of care. Soleo Health\u2019s interdisciplinary clinical team comprises highly experienced pharmacists, registered nurses, reimbursement specialists and patient care ambassadors. The Company optimizes patient access solutions and delivers comprehensive services, leading to quantifiable clinical and economic value, resulting in positive patient experiences.\n<\/p>\n

\nSoleo Health operates 21 locations<\/a> throughout the U.S. with national nursing coverage and pharmacy licensure in 50 states and is accredited by URAC, ACHC with Distinction in Rare Disease and Orphan Drugs and The Joint Commission.\n<\/p>\n

\nVisit www.soleohealth.com<\/a> or connect with Soleo Health on LinkedIn<\/a>,<\/span> Facebook<\/a> and Twitter<\/a> for more information.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSusan Turkell, 303-766-4343, sturkell@soleohealth.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Company to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare–Headline of release dated July 26, 2022, should read: Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae The updated release reads: SOLEO HEALTH SELECTED AS LIMITED DRUG DISTRIBUTION PARTNER FOR ADMINISTRATION OF LEQVIO\u00ae Company to Distribute Recent FDA-Approved Treatment … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46809","6":"format-standard","7":"category-industry"},"yoast_head":"\nCORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Company to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare–Headline of release dated July 26, 2022, should read: Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae The updated release reads: SOLEO HEALTH SELECTED AS LIMITED DRUG DISTRIBUTION PARTNER FOR ADMINISTRATION OF LEQVIO\u00ae Company to Distribute Recent FDA-Approved Treatment ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-02T00:01:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220726005168\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae\",\"datePublished\":\"2022-08-02T00:01:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/\"},\"wordCount\":417,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220726005168\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/\",\"name\":\"CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220726005168\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\",\"datePublished\":\"2022-08-02T00:01:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220726005168\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220726005168\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/","og_locale":"en_US","og_type":"article","og_title":"CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae - Pharma Trend","og_description":"Company to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare–Headline of release dated July 26, 2022, should read: Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae The updated release reads: SOLEO HEALTH SELECTED AS LIMITED DRUG DISTRIBUTION PARTNER FOR ADMINISTRATION OF LEQVIO\u00ae Company to Distribute Recent FDA-Approved Treatment ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-02T00:01:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220726005168\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae","datePublished":"2022-08-02T00:01:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/"},"wordCount":417,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220726005168\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/","url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/","name":"CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220726005168\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","datePublished":"2022-08-02T00:01:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220726005168\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220726005168\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-soleo-health-selected-as-limited-drug-distribution-partner-for-administration-of-leqvio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46809"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46809\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}